• Zum Hauptinhalt springen
  • Zum Footer springen

DFG-Forscher...

  • About
  • News
  • Projects
    • Project 1 - Development of a Gene Therapy for Usher Syndrome Type 1B (USH1B)
    • Project 2 - Evaluation of novel gene therapy approaches for USH2A
    • Project 3 - Retina organoids as models for assessing pathomechanisms and effects of novel treatments inn retinal disorders
    • Project 4 - Development of a one-time gene therapy for age-related macular degeneration
    • Project 5 - Development of novel gene therapy strategies for treatment of autosomal dominant retinitis pigmentosa in a pig model
    • Project 6 - Novel targets for gene therapy in diabetic retinopathy (DR)
    • Project 7 - RPE plasticity in the context of neurodegenerative disease: Understanding the limits, pushing the boundaries
    • Project 8 - Novel AI-based biomarkers for retinal gene therapy outcomes by integrating functional neuroimaging and retinal imaging
    • Project 9 - Integrating imaging, clinical and genetic data with machine learning to establish biomarkers for retinal diseases
  • Project leaders
  • Publications
  1. DFG-Forschergruppe 5621
  2. Prof. Dr. Susanne Koch

Prof. Dr. Susanne Koch

Project 7

Susanne Koch is Professor of Molecular Pharmacology at the Department of Pharmacy, LMU Munich and DFG Emmy Noether Group Leader. Her research focuses on the elucidation of factors which influence the outcome of retinal gene therapy.

:cfcJguauisoüyzy,fö-ävf mi
Website

FOR 5621 Research unit

Coordination

Mathildenstr. 8
80336 Munich
+49 89 2180 77337
wüp6412;v;imeful_vfiuyYziusmi
Editor login
Imprint | Data-Safety